Back to Search
Start Over
Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.
- Source :
- Investigational New Drugs; Oct2017, Vol. 35 Issue 5, p669-669, 1p
- Publication Year :
- 2017
- Subjects :
- ANTINEOPLASTIC agents
TUMORS
Subjects
Details
- Language :
- English
- ISSN :
- 01676997
- Volume :
- 35
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Investigational New Drugs
- Publication Type :
- Academic Journal
- Accession number :
- 125326143
- Full Text :
- https://doi.org/10.1007/s10637-017-0479-3